Intra-Cellular Therapies Announces Amended Start Time to Virtual Event on Wednesday, October 20
Webcast to begin at
Virtual event to include discussions on our lumateperone, ITI-1284, PDE1 inhibitors, and ITI-333 platforms
The live and archived webcast can be accessed under "Events & Presentations" on the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.
Vice President, Corporate Communications and Investor Relations
Source: Intra-Cellular Therapies Inc.